Icon Advisers’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-18,665
| Closed | -$2.5M | – | 136 |
|
|
2022
Q3 | $2.5M | Sell |
18,665
-24,761
| -57% | -$3.55M | 0.69% | 50 |
|
|
2022
Q2 | $6.65M | Sell |
43,426
-3,400
| -7% | -$520K | 1.54% | 12 |
|
|
2022
Q1 | $7.59M | Sell |
46,826
-11,760
| -20% | -$1.71M | 1.29% | 15 |
|
|
2021
Q4 | $7.93M | Hold |
58,586
| – | – | 1.27% | 16 |
|
|
2021
Q3 | $6.32M | Hold |
58,586
| – | – | 1.07% | 19 |
|
|
2021
Q2 | $6.6M | Hold |
58,586
| – | – | 1.08% | 18 |
|
|
2021
Q1 | $6.34M | Hold |
58,586
| – | – | 0.99% | 28 |
|
|
2020
Q4 | $6.28M | Sell |
58,586
-3,300
| -5% | -$317K | 1.14% | 22 |
|
|
2020
Q3 | $5.42M | Buy |
61,886
+18,000
| +41% | +$1.69M | 1.07% | 19 |
|
|
2020
Q2 | $4.31M | Buy |
43,886
+10,565
| +32% | +$930K | 0.84% | 24 |
|
|
2020
Q1 | $2.54M | Buy |
33,321
+7,100
| +27% | +$605K | 0.55% | 59 |
|
|
2019
Q4 | $2.32M | Hold |
26,221
| – | – | 0.33% | 106 |
|
|
2019
Q3 | $1.99M | Sell |
26,221
-63,768
| -71% | -$4.37M | 0.29% | 121 |
|
|
2019
Q2 | $6.54M | Sell |
89,989
-15,000
| -14% | -$1.18M | 0.62% | 46 |
|
|
2019
Q1 | $8.46M | Buy |
104,989
+5,900
| +6% | +$483K | 0.85% | 31 |
|
|
2018
Q4 | $9.13M | Hold |
99,089
| – | – | 0.96% | 29 |
|
|
2018
Q3 | $9.37M | Sell |
99,089
-17,846
| -15% | -$1.69M | 0.79% | 37 |
|
|
2018
Q2 | $10.8M | Sell |
116,935
-4,123
| -3% | -$403K | 0.82% | 42 |
|
|
2018
Q1 | $11.5M | Buy |
121,058
+63,958
| +112% | +$7.03M | 0.87% | 34 |
|
|
2017
Q4 | $5.52M | Hold |
57,100
| – | – | 0.38% | 77 |
|
|
2017
Q3 | $5.07M | Sell |
57,100
-23,700
| -29% | -$1.8M | 0.36% | 98 |
|
|
2017
Q2 | $5.86M | Sell |
80,800
-104,500
| -56% | -$7.03M | 0.41% | 83 |
|
|
2017
Q1 | $12.1M | Buy |
185,300
+4,900
| +3% | +$308K | 0.83% | 22 |
|
|
2016
Q4 | $11.3M | Buy |
180,400
+15,000
| +9% | +$916K | 0.76% | 27 |
|
|
2016
Q3 | $10.4M | Sell |
165,400
-52,400
| -24% | -$3.39M | 0.69% | 27 |
|
|
2016
Q2 | $13.5M | Buy |
217,800
+1,700
| +0.8% | +$104K | 0.92% | 17 |
|
|
2016
Q1 | $12.3M | Sell |
216,100
-32,000
| -13% | -$1.78M | 0.88% | 21 |
|
|
2015
Q4 | $14.7M | Hold |
248,100
| – | – | 1.01% | 15 |
|
|
2015
Q3 | $13.5M | Hold |
248,100
| – | – | 0.93% | 25 |
|
|
2015
Q2 | $16.7M | Sell |
248,100
-35,000
| -12% | -$2.28M | 1.05% | 25 |
|
|
2015
Q1 | $16.6M | Buy |
283,100
+158,600
| +127% | +$9.58M | 0.97% | 25 |
|
|
2014
Q4 | $8.15M | Sell |
124,500
-39,000
| -24% | -$2.46M | 0.48% | 77 |
|
|
2014
Q3 | $9.44M | Buy |
163,500
+72,600
| +80% | +$4.03M | 0.55% | 59 |
|
|
2014
Q2 | $5.13M | Buy |
90,900
+6,900
| +8% | +$362K | 0.32% | 78 |
|
|
2014
Q1 | $4.32M | Hold |
84,000
| – | – | 0.31% | 86 |
|
|
2013
Q4 | $4.44M | Hold |
84,000
| – | – | 0.32% | 83 |
|
|
2013
Q3 | $3.76M | Buy |
+84,000
| New | +$3.72M | 0.29% | 88 |
|
Other funds holding ABBV
AWA
Icon Advisers's ABBV Position: Q4 2022 in Review
Icon Advisers sold out of AbbVie (ABBV) in Q4 2022, closing a stake of 18,665 shares — an estimated $2.5M sold.
Icon Advisers first reported a position in ABBV in Q3 2013 and held it in 37 quarters. The position peaked at $16.7M in Q2 2015. 3,167 funds tracked by Wall St. Rank hold ABBV as of Q4 2022.
- Icon Advisers reported no remaining AbbVie position as of Q4 2022 after selling out during the quarter.
- Icon Advisers sold 18,665 AbbVie shares in Q4 2022, an estimated $2.5M.
- Icon Advisers first reported a position in AbbVie in Q3 2013 and held it in 37 quarters.
- Icon Advisers's AbbVie position peaked at $16.7M in Q2 2015.
- 3,167 funds tracked by Wall St. Rank held AbbVie as of Q4 2022.
Based on Icon Advisers's 13F filing for Q4 2022, filed 14 Feb 2023.